Literature DB >> 21393135

Transfer of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae from Turkey to France.

Marion Levast, Laurent Poirel, Amélie Carrër, Michel Deiber, Emmanuel Decroisette, Frank-Olivier Mallaval, Claire Lecomte, Patrice Nordmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21393135     DOI： 10.1093/jac/dkq504

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  11 in total

1.  Emergence of OXA-48-producing Escherichia coli clone ST38 in France.

Authors:  Laurent Poirel; Sandrine Bernabeu; Nicolas Fortineau; Isabelle Podglajen; Christine Lawrence; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

2.  Sequence-based epidemiology of an OXA-48 plasmid during a hospital outbreak.

Authors:  Laura Hidalgo; Mark de Been; Malbert R C Rogers; Anita C Schürch; Jelle Scharringa; Anneke van der Zee; Marc J M Bonten; Ad C Fluit
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

Review 3.  The Global Ascendency of OXA-48-Type Carbapenemases.

Authors:  Johann D D Pitout; Gisele Peirano; Marleen M Kock; Kathy-Anne Strydom; Yasufumi Matsumura
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

4.  OXA-163, an OXA-48-related class D β-lactamase with extended activity toward expanded-spectrum cephalosporins.

Authors:  Laurent Poirel; Mariana Castanheira; Amélie Carrër; Carla Parada Rodriguez; Ronald N Jones; Jorgelina Smayevsky; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

5.  Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.

Authors:  Olivier Mimoz; Nicolas Grégoire; Laurent Poirel; Manuella Marliat; William Couet; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

Review 6.  OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.

Authors:  Assia Mairi; Alix Pantel; Albert Sotto; Jean-Philippe Lavigne; Aziz Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-08       Impact factor: 3.267

Review 7.  Treatment of Infections by OXA-48-Producing Enterobacteriaceae.

Authors:  Adam Stewart; Patrick Harris; Andrew Henderson; David Paterson
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

8.  Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model.

Authors:  Dora E Wiskirchen; Patrice Nordmann; Jared L Crandon; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2013-12-30       Impact factor: 5.191

Review 9.  Laboratory Detection and Clinical Implication of Oxacillinase-48 like Carbapenemase: The Hidden Threat.

Authors:  Yamuna Devi Bakthavatchalam; Shalini Anandan; Balaji Veeraraghavan
Journal:  J Glob Infect Dis       Date:  2016 Jan-Mar

10.  Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.

Authors:  Luigi Segagni Lusignani; Elisabeth Presterl; Beata Zatorska; Miriam Van den Nest; Magda Diab-Elschahawi
Journal:  Antimicrob Resist Infect Control       Date:  2020-01-17       Impact factor: 4.887
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.